ICU Medical Inc. (ICUI)
ICU Medical Statistics
Share Statistics
ICU Medical has 24.52M shares outstanding. The number of shares has increased by 0.63% in one year.
Shares Outstanding | 24.52M |
Shares Change (YoY) | 0.63% |
Shares Change (QoQ) | 0.14% |
Owned by Institutions (%) | 98.92% |
Shares Floating | 22.59M |
Failed to Deliver (FTD) Shares | 3 |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 780.22K, so 3.18% of the outstanding shares have been sold short.
Short Interest | 780.22K |
Short % of Shares Out | 3.18% |
Short % of Float | 3.45% |
Short Ratio (days to cover) | 2.99 |
Valuation Ratios
The PE ratio is -32.16 and the forward PE ratio is 17.2. ICU Medical's PEG ratio is -0.11.
PE Ratio | -32.16 |
Forward PE | 17.2 |
PS Ratio | 1.59 |
Forward PS | 1.3 |
PB Ratio | 1.93 |
P/FCF Ratio | 30.36 |
PEG Ratio | -0.11 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for ICU Medical.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.59, with a Debt / Equity ratio of 0.81.
Current Ratio | 2.59 |
Quick Ratio | 1.54 |
Debt / Equity | 0.81 |
Debt / EBITDA | 36.84 |
Debt / FCF | 12.7 |
Interest Coverage | 0.4 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $158.8K |
Profits Per Employee | $-7.85K |
Employee Count | 15,000 |
Asset Turnover | 0.57 |
Inventory Turnover | 2.66 |
Taxes
Income Tax | 51.68M |
Effective Tax Rate | -78.28% |
Stock Price Statistics
The stock price has increased by 44.84% in the last 52 weeks. The beta is 0.87, so ICU Medical's price volatility has been higher than the market average.
Beta | 0.87 |
52-Week Price Change | 44.84% |
50-Day Moving Average | 148.59 |
200-Day Moving Average | 156.29 |
Relative Strength Index (RSI) | 46.93 |
Average Volume (20 Days) | 278.37K |
Income Statement
In the last 12 months, ICU Medical had revenue of 2.38B and earned -117.69M in profits. Earnings per share was -4.83.
Revenue | 2.38B |
Gross Profit | 824.78M |
Operating Income | 42.96M |
Net Income | -117.69M |
EBITDA | 42.96M |
EBIT | 40.53M |
Earnings Per Share (EPS) | -4.83 |
Balance Sheet
The company has 308.57M in cash and 1.58B in debt, giving a net cash position of -1.27B.
Cash & Cash Equivalents | 308.57M |
Total Debt | 1.58B |
Net Cash | -1.27B |
Retained Earnings | 690.16M |
Total Assets | 4.2B |
Working Capital | 885.8M |
Cash Flow
In the last 12 months, operating cash flow was 204.03M and capital expenditures -79.37M, giving a free cash flow of 124.66M.
Operating Cash Flow | 204.03M |
Capital Expenditures | -79.37M |
Free Cash Flow | 124.66M |
FCF Per Share | 5.11 |
Margins
Gross margin is 34.62%, with operating and profit margins of 1.8% and -4.94%.
Gross Margin | 34.62% |
Operating Margin | 1.8% |
Pretax Margin | -2.77% |
Profit Margin | -4.94% |
EBITDA Margin | 1.8% |
EBIT Margin | 1.8% |
FCF Margin | 5.23% |
Dividends & Yields
ICUI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for ICUI is $200, which is 43.3% higher than the current price. The consensus rating is "Buy".
Price Target | $200 |
Price Target Difference | 43.3% |
Analyst Consensus | Buy |
Analyst Count | 4 |
Stock Splits
The last stock split was on Mar 18, 2002. It was a forward split with a ratio of 3:2.
Last Split Date | Mar 18, 2002 |
Split Type | forward |
Split Ratio | 3:2 |
Scores
Altman Z-Score | 2.02 |
Piotroski F-Score | 6 |